Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details) - shares |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Potential common shares | ||||
| Total (in shares) | 9,189,246 | 8,113,706 | 9,189,246 | 8,113,706 |
| Common stock options and restricted stock units | ||||
| Potential common shares | ||||
| Total (in shares) | 4,184,833 | 2,956,910 | 4,184,833 | 2,956,910 |
| Warrants to purchase common stock | ||||
| Potential common shares | ||||
| Total (in shares) | 692,272 | 692,523 | 692,272 | 692,523 |
| Preferred stock | Series A Preferred Stock | ||||
| Potential common shares | ||||
| Total (in shares) | 3,268,345 | 4,026,346 | 3,268,345 | 4,026,346 |
| Preferred stock | Series B Preferred Stock | ||||
| Potential common shares | ||||
| Total (in shares) | 437,927 | 437,927 | 437,927 | 437,927 |
| Conversion Option | ||||
| Potential common shares | ||||
| Total (in shares) | 605,869 | 0 | 605,869 | 0 |